Has Stuart Hardy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,823 in general payments to Stuart Hardy, MD across 115 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stuart Hardy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stuart Hardy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stuart Hardy, MD

Otolaryngology · Wilmington, NCNPI 1386608495

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,277 of the $4,823 with a category attached, or 67.9%. It is spread thinly across 25 manufacturers, the largest accounting for just 23.6%.

$4,823in general payments, 2019–2025

Across 115 payments — averaging $41.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$1K
Livanova USA, Inc.$701
GSK$569
Medtronic$431
Sanofi$358
Stryker$314
plus $1K from 19 others

What the payments were for

Speaking & faculty fees$46810%
Travel & lodging$1,03822%
Food & beverage$3,27768%
Education$341%
Gifts$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	3	$1,140
Livanova USA, Inc.	5	$701
GSK	21	$569
Medtronic(2 entities)	7	$431
Sanofi	14	$358
Stryker	9	$314
Regeneron Healthcare Solutions, Inc.	9	$258
Acclarent, Inc	3	$159
Aerin Medical Inc.	8	$154
Intersect ENT, Inc.	2	$150
Optinose US, Inc.	9	$140
Amgen	6	$128
Vertex	2	$47
Phathom Pharmaceuticals, Inc.	3	$35
Novartis	2	$34
Integra Lifesciences Corporation	2	$29
Smith+Nephew	1	$26
Jubilant Hollisterstier LLC	1	$24
Kaleo, Inc.	2	$22
Resmed Corp	1	$22
Merck	1	$19
Kowa Pharmaceuticals America, Inc.	1	$18
AstraZeneca	1	$14
Greer Laboratories, Inc.	1	$14
Arbor Pharmaceuticals, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire Upper Airway Stimulation System$1,038
VNS THERAPY SENTIVA MODEL 1000 GENERATOR$599
NUCALA$243
STEALTHSTATION S8 PLATFORM$145
TruDi Nav Cable$132
SINUVA$129
AUDION ET DILATION SYSTEM$127
PROPEL$126

How this compares

$4,823 in reported general payments places this provider in the 85th percentile of 362 otolaryngology providers in North Carolina.

See all otolaryngology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$314,191

Medicare patients

1,390

Services billed

4,161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	19	$66,801
Ipratropium Bromide	121	$5,060
Omeprazole	129	$2,427
CefuroximeCefuroxime Axetil	100	$2,163
Fluticasone Propionate	107	$2,004
Azelastine Hcl	69	$1,673
Pantoprazole Sodium	89	$1,649
Fluocinonide	59	$1,357
Ofloxacin	44	$1,192
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	11	$1,063
Prednisone	78	$438
Clindamycin Hcl	31	$389
Gabapentin	36	$263
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid	23	$262
Clonazepam	59	$239

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Wilmington

S VonbibersteinWilmington$5K
John RocheWilmington$4K
David JangDurham$324K
Robert FerrisRaleigh$258K
Adam ZanationHickory$227K
Brent SeniorChapel Hill$91K
Charles EbertChapel Hill$57K
Adam CampbellWinston Salem$47K
Harold PillsburyChapel Hill$42K
John BuentingSylva$30K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →